Individualized treatment with infliximab therapy in children with Crohn’s disease support shorter time intervals between infusions

摘要

ObjectivesTo study the effect of an individualized treatment approach with regard to dosage intervals between infliximab infusions on the clinical outcome of pediatric Crohn’s disease (CD).